Cargando…

The 2020 revision of the guidelines for the management of myeloproliferative neoplasms

In 2016, the World Health Organization revised the diagnostic criteria for myeloproliferative neoplasms (MPNs) based on the discovery of disease-driving genetic aberrations and extensive analysis of the clinical characteristics of patients with MPNs. Recent studies have suggested that additional som...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung-Yong, Bae, Sung Hwa, Bang, Soo-Mee, Eom, Ki-Seong, Hong, Junshik, Jang, Seongsoo, Jung, Chul Won, Kim, Hee-Jin, Kim, Ho Young, Kim, Min Kyoung, Kim, Soo-Jeong, Mun, Yeung-Chul, Nam, Seung-Hyun, Park, Jinny, Won, Jong-Ho, Choi, Chul Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820646/ https://www.ncbi.nlm.nih.gov/pubmed/33147902 http://dx.doi.org/10.3904/kjim.2020.319

Ejemplares similares

Guidelines for the management of myeloproliferative neoplasms
por: Choi, Chul Won, et al.
Publicado: (2015)

How myeloproliferative neoplasms patients’ experience and expectations differ from physicians’: the international MPN Landmark survey
por: Byun, Ja Min, et al.
Publicado: (2022)

The puzzle of myeloproliferative neoplasms: novel disease-specific mutations and new proposals for diagnostic criteria
por: Kim, Hee-Jin, et al.
Publicado: (2014)

Effects of CALR-Mutant Type and Burden on the Phenotype of Myeloproliferative Neoplasms
por: Kim, Hyun-Young, et al.
Publicado: (2022)

Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms
por: Kim, Jinyong, et al.
Publicado: (2021)

Recent insights regarding the molecular basis of myeloproliferative neoplasms
por: Jang, Mi-Ae, et al.
Publicado: (2020)

Updated recommendations for the treatment of venous thromboembolism
por: Hong, Junshik, et al.
Publicado: (2021)

Genetic–pathologic characterization of myeloproliferative neoplasms
por: Kim, Yonggoo, et al.
Publicado: (2016)

Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines
por: Bang, Soo-Mee, et al.
Publicado: (2014)

Prognostication in myeloproliferative neoplasms, including mutational abnormalities
por: Hong, Junshik
Publicado: (2023)

A call for vigilance: thrombotic thrombocytopenic syndrome caused by mRNA COVID-19 vaccine associated with muscle weakness
por: Kim, Chul Soo, et al.
Publicado: (2022)

Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP)
por: Hong, Junshik, et al.
Publicado: (2018)

Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea
por: Lim, Yoojoo, et al.
Publicado: (2016)

Clinical Factors Associated with Response or Survival after Chemotherapy in Patients with Waldenström Macroglobulinemia in Korea
por: Lee, Ho Sup, et al.
Publicado: (2014)

GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms
por: Yang, Naery, et al.
Publicado: (2018)

Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era
por: Lee, Jong-Mi, et al.
Publicado: (2021)

Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome
por: Suh, Koung Jin, et al.
Publicado: (2016)

The clinical role of interferon alpha in Philadelphia-negative myeloproliferative neoplasms
por: Yoon, Seug Yun, et al.
Publicado: (2021)

Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial
por: Yhim, Ho-Young, et al.
Publicado: (2019)

Myelodysplasia-Related Features of Acute Myeloid Leukemia Evolving From Philadelphia-Negative Myeloproliferative Neoplasms
por: Kim, Jae-Ryuk, et al.
Publicado: (2016)

The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)
por: Jung, Sung-Hoon, et al.
Publicado: (2017)

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)
por: Lee, Ho Sup, et al.
Publicado: (2020)

Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study
por: Kim, Yu Ri, et al.
Publicado: (2023)

Long-acting interferon: pioneering disease modification of myeloproliferative neoplasms
por: Yoon, Seug Yun, et al.
Publicado: (2023)

Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study
por: Jeong, Seong Hyun, et al.
Publicado: (2015)

Korean Patients with Superwarfarin Intoxication and Their Outcome
por: Hong, Junshik, et al.
Publicado: (2010)

PB2212: ABDOMINAL AORTIC CALCIFICATION IN PATIENTS NEWLY DIAGNOSED WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASM
por: Lee, Myung-Won, et al.
Publicado: (2023)

Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study
por: Jeon, Youngwoo, et al.
Publicado: (2023)

Concomitant ruxolitinib with cytarabine-based induction chemotherapy in secondary acute myeloid leukemia evolving from myeloproliferative neoplasm
por: Kim, Dong Hyun, et al.
Publicado: (2023)

Presence of Polyclonal Hematopoiesis in Females with Ph-negative Myeloproliferative Neoplasms
por: Swierczek, Sabina, et al.
Publicado: (2015)

Splenic Infarction in Patients with Philadelphia-negative Myeloproliferative Neoplasms
por: Lee, Myung-Won, et al.
Publicado: (2022)

Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
por: Ha, Hyerim, et al.
Publicado: (2023)

Feasibility and outcomes of laparoscopic enucleation for pancreatic neoplasms
por: Choi, Kyu Sung, et al.
Publicado: (2014)

Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura
por: Bae, Sung Hwa, et al.
Publicado: (2022)

Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms
por: Lim, Sung-Nam, et al.
Publicado: (2013)

Android Fat Depot Is More Closely Associated with Metabolic Syndrome than Abdominal Visceral Fat in Elderly People
por: Kang, Seon Mee, et al.
Publicado: (2011)

HDAC4 degradation by combined TRAIL and valproic acid treatment induces apoptotic cell death of TRAIL-resistant head and neck cancer cells
por: Lee, Bok-Soon, et al.
Publicado: (2018)

Early Response to Bortezomib Combined Chemotherapy Can Help Predict Survival in Patients with Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation
por: Lee, Ho Sup, et al.
Publicado: (2013)

A Survey of Diabetic Educators and Patients for the Revision of Korean Food Exchange Lists
por: Cho, Jae Won, et al.
Publicado: (2011)

Future and Development Direction of Digital Healthcare
por: Kim, Hun-Sung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eu5nonmqch53ot7ou2irnt814o